CCCC
C4 Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.72
-0.03 ▼ -1.09%
🌙 3월 13일 7:32 PM ET (한국 3/14 08:32)
$2.75
+0.03 ▲ +1.01%
| Index | - | P/E | - | EPS (ttm) | -1.36 | Insider Own | 16.3% | Shs Outstand | 0.10B | Perf Week | -10.53% |
| Market Cap | 0.27B | Forward P/E | - | EPS next Y | 9.68% | Insider Trans | -0.06% | Shs Float | 0.08B | Perf Month | 48.63% |
| Enterprise Value | 0.08B | PEG | - | EPS next Q | -0.27 | Inst Own | 73.08% | Short Float | 10.43% | Perf Quarter | 5.43% |
| Income | -0.10B | P/S | 7.38 | EPS this Y | 13.99% | Inst Trans | 4.33% | Short Ratio | 4.05 | Perf Half Y | -0.37% |
| Sales | 0.04B | P/B | 1.03 | EPS next 5Y | -0.57% | ROA | -29.1% | Short Interest | 8.52M | Perf YTD | 42.41% |
| Book/sh | 2.65 | P/C | 1.07 | EPS past 3/5Y | 21.55% 3.84% | ROE | -44.44% | 52W High | -28.8% ($3.82) | Perf Year | 34.65% |
| Cash/sh | 2.55 | P/FCF | - | Sales past 3/5Y | 4.95% 1.61% | ROIC | -33.85% | 52W Low | 150.69% ($1.09) | Perf 3Y | -38.74% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 10.49% | Gross Margin | 77.81% | Volatility(W/M) | 14.42% 12.24% | Perf 5Y | -93.91% |
| Dividend TTM | - | EV/Sales | 2.14 | Sales Y/Y TTM | 1.02% | Oper. Margin | -290.68% | ATR (14) | 0.31 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.81 | EPS Q/Q | 64.18% | Profit Margin | -292.08% | RSI (14) | 52.3 | Recom | 1.12 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.81 | Sales Q/Q | 112.79% | SMA20 | 2.06% ($2.67) | Beta | 2.89 | Target Price | $11.57 |
| Payout | - | Debt/Eq | 0.23 | Earnings | 2000000 | SMA50 | 19% ($2.29) | Rel Volume | 0.88 | Prev Close | $2.75 |
| Employees | 104 | LT Debt/Eq | 0.21 | EPS/Sales Surpr. | 37.5% 104.2% | SMA200 | 20.36% ($2.26) | Avg Volume(3M) | 2.10M | Price | $2.72 |
| IPO | 2020/10/2 | Option/Short | Yes/Yes | Trades | 6013 | Volume | 1,855,147 | Change | -1.09% |
뉴스 로딩 중...